JP Morgan
Singular Genomics Ups IPO Target to $187M
The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option.
JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More
Exact Sciences discussed new Cologuard data; Danaher reviewed Cepheid's 2020 performance; and NanoString talked about forthcoming spatial biology products.
JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More
Qiagen's CEO discussed the company's focus on specific growth drivers, while Invitae's CEO talked about pandemic-related challenges in its genetic testing business.